Unaudited Condensed Statement of Cash Flows	9 Months Ended
	Mar. 31, 2021 USD ($)
Cash Flows from Operating Activities:
Net income	$ 1,828,787
Adjustments to reconcile net income to net cash used in operating activities:
Change in fair value of derivative warrant liabilities	(2,438,770)
Financing cost - derivative warrant liabilities	314,650
General and administrative expenses paid by Sponsor through note payable	24,589
Gain on investments held in Trust Account	(44,606)
Changes in operating assets and liabilities:
Prepaid expenses	(207,559)
Accounts payable	55,363
Franchise tax payable	168,219
Accrued expenses	(3,300)
Net cash used in operating activities	(302,627)
Cash Flows from Investing Activities
Cash deposited in Trust Account	(116,725,000)
Net cash used in investing activities	(116,725,000)
Cash Flows from Financing Activities:
Proceeds received from initial public offering, gross	115,000,000
Proceeds received from private placement	5,525,000
Offering costs paid	(2,572,778)
Net cash provided by financing activities	117,952,222
Net increase in cash	924,595
Cash - beginning of the period
Cash - end of the period	924,595
Supplemental disclosure of noncash activities:
Offering costs included in accrued expenses	86,300
Offering costs included in note payable	77,370
Deferred underwriting commissions in connection with the initial public offering	4,025,000
Initial value of common stock subject to possible redemption	99,596,905
Change in value of common stock subject to possible redemption	$ 3,707,410